MedTrace Logo

Potential Effects of Intermittent Fasting to Metabolic Syndrome

NCT03608800 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2020-05-27

No results posted yet for this study

Summary

The survey is designed to investigate whether 8 weeks of discrete two-day intermittent fasting per week will impact gut microbiota and cardiovascular risks of metabolic syndrome subjects.

Conditions

  • Metabolic Syndrome

Interventions

BEHAVIORAL

Intermittent fasting

The intervention of two nonconsecutive days of 75% energy restriction per week for 8 weeks

Sponsors & Collaborators

  • Min Xia

    lead OTHER

Principal Investigators

  • Min Xia, Doctor · Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-30
Primary Completion
2019-05-30
Completion
2019-05-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03608800 on ClinicalTrials.gov